top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Baxter CEO José Almeida Retires; Brent Shafer Appointed Interim CEO

1 min read

Deerfield, Ill, February 2, 2025 (Baxter) -- Baxter International announces the retirement of CEO José Almeida, effective immediately, with Brent Shafer appointed as interim CEO. Shafer steps down from his lead independent director role, which will be taken over by Nancy Schlichting. The company is now searching for a permanent CEO following a transformative period under Almeida's leadership.

Read full article here.

Recent Posts

Latigo Biotherapeutics secures $150M series B to advance non-opioid pain treatments

Thousands Oak, CA, March 17, 2025 (PRNewswire) -- Latigo Biotherapeutics, a clinical-stage biotechnology company, has successfully...

David Pacitti departs Siemens Healthineers to lead Avanos Medical as CEO

Alpharetta, GA, March 17, 2025 (PRNewswire) -- David Pacitti is leaving Siemens Healthineers to become CEO of Avanos Medical after...

AstraZeneca to Acquire EsoBiotec for Up to $1B to Enhance Cancer Cell Therapy Capabilities

Cambridge, UK, March 17, 2025 (Reuters) -- AstraZeneca has announced its agreement to acquire Belgium-based biotechnology firm...

Comments

Life Science Headlines

Latigo Biotherapeutics secures $150M series B to advance non-opioid pain treatments

David Pacitti departs Siemens Healthineers to lead Avanos Medical as CEO

AstraZeneca to Acquire EsoBiotec for Up to $1B to Enhance Cancer Cell Therapy Capabilities

Gensaic and Novo Nordisk Forge $354M Partnership to Advance Precision Therapies

Openwater Names Aaron Timm as CEO to Drive Growth in Portable Imaging and Therapy Devices

AbbVie Enters Obesity Drug Race with $2.25B Licensing Deal for Gubra’s Amylin Analog

Nimbus Therapeutics Appoints Abbas Kazimi as CEO Amid Strategic Transition

Roche Strikes $5.3B Deal with Zealand Pharma to Expand in Obesity Market

OrganOx Secures $142M in Equity Financing to Drive Growth in Organ Technology

Valencia Technologies Announces $35M Investment and Appoints Jim Surek as CEO to Drive Growth

bottom of page